Aurora Oncology
Dr. Glode has been a key clinical investigator in a number of urologic oncology trials and was co-PI on Phase I, II, and III studies that led to the FDA approval of leuprolide. He continues to serve as a scientific advisor to a number of pharmaceutical companies in the urologic oncology space, including Jansen, Dendreon, Medivation, and Exelixis among others.
This person is not in the org chart
This person is not in any offices